This finding is particularly intriguing, as GPC1 is a cell surface proteoglycan that is capable of enhancing signaling of cell surface receptors, promoting increased cellular proliferation and has been linked to the development of cancer in various models [37, 38]. Here, CD177 is linked to cancer.